Clinical Trials
2 trialsNCT06506955 2026-05-28
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT00068003 2026-05-01
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
Enrolling by invitation